Siemens Inks Deal With Wyeth For Imaging Agent

Friday, March 9, 2007 12:10 PM

Siemens Medical Solutions’ molecular imaging division has inked an agreement with Wyeth Pharmaceuticals to use a new Alzheimer’s disease imaging agent in its clinical trials.

The agent, which just recently received approval from the U.S. Food and Drug Administration (FDA), works differently then traditional molecular imaging agents such as PET scans that are less specific. The new agent is the first to specifically identify the accumulation of amyloid plaques and neuronal tangles that cause cell death in the brain.

“Molecular imaging is already revolutionizing the detection and diagnosis of diseases like Alzheimer’s; and now, it is becoming an indispensable component in the development of exciting new drug therapies, improving patient health,” said Michael Reitermann, president, Molecular Imaging, Siemens Medical Solutions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs